November 14-15, 2022 | Washington, DC 


Learn about the latest technologies, partnerships and advances propelling the field of repurposing and re-shaping drug discovery and development


The next Drug Repositioning & Repurposing Conference will be taking place in Spring/Summer 2024. Please check back in the coming weeks and months for updates.

2016 Speakers

The FULL speaking faculty for the 5th Annual Drug Repositioning Conference has not yet been announced. Please check back in the coming weeks and months for additional information. Speakers to date include:

Dr. Bruce E. Bloom, President and Chief Science Officer, Cures Within Reach

Leslie Cousens, Ph.D., Associate Director, Translational Medicine, Emerging Innovations, AstraZeneca

Matthew DeSilva, CEO, Notable Labs

Nandu Gattu, Ph.D., VP Drug Repurposing, Excelra - Knowledge Solutions

Katsuhisa Horimoto, Ph.D., Deputy Director, Molecular Profiling Research Center for Drug Discovery, National Institute of Advanced Industrial Science and Technology

Kim Kaiser-Rachidi, Special Consultant-Industry Relations, Alliance for Lupus Research

Burcu Kucukkeles, Research Associate & Doctoral Candidate, Department of Management, Technology and Economics, Chair of Strategic Management and Innovation, ETH Zurich

Daphna Laifenfeld, Ph.D., Director, Personalized and Predictive Medicine and Big Data Analytics, Teva Pharmaceuticals 

Vimal Mehta, Ph.D., Chairman and Chief Executive Officer, BioXcel

Hermann Mucke, Ph.D., Principal, HM Pharma Consultancy

Stephen Naylor, Ph.D., Chairman & CEO, MaiHealth Inc.

Aytekin Oto, MD, Professor of Radiology, Section Chief, Abdominal Imaging, Chief of Body MRI, The University of Chicago

Aris Persidis, Ph.D., President, Biovista

Kenneth Phelps, President and CEO, Camargo Pharmaceutical Services

Lakshminarayan Ranganath, Ph.D., Director, National AKU Centre, Coordinator, DevelopAKUre Consortium, Honorary Professor in Musculoskeletal Biology, University of Liverpool, Consultant, Royal Liverpool University Hospital

Al Roy, Executive Director, Lupus Clinical Investigators Network, Alliance for Lupus Research

Adriann Sax, MBA, Entrepreneur in Residence, Fortress Biotech

Daniel Sem, Ph.D., MBA, Dean and Professor of Business, Professor of Pharmaceutical Sciences, Concordia University Wisconsin

Larry Sklar, Ph.D., The Maralyn S. Budke and Robert E. Anderson Distinguished Endowed Chair in Cancer Drug Discovery, Director, UNM Center for Molecular Discovery, The University of New Mexico School of Medicine

Paul Spagnuolo, Ph.D., Assistant Professor, University of Waterloo

Marty St. Clair, Ph.D., Clinical Virology, ViiV Healthcare

Vikram Sudarsan, Head, Cipla Technologies, Cipla New Ventures

Rose Thiessen, Ph.D., Partner, Knobbe, Martens, Olson & Bear, LLP

Jason Tsai, MD, MS, VP Translational Medicine, Numedii

Jerome Zeldis, MD, Ph.D., Chief Executive Officer, Celgene Global Health, Chief Medical Officer, Celgene Corporation

Alice Zhang, Chief Executive Officer, Verge Genomics

Wei Zheng, Ph.D., Leader, Biology, Therapeutics for Rare and Neglected Diseases, Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health

Contact Us

Arrowhead Publishers
PO Box 96
Chanhassen, MN 55317


About Us

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward.